Dovetail Genomics Receives $2M SBIR Grant for Oncology Solutions
Dovetail Genomics, a notable player in genomics innovation, has secured a $2 million Small Business Innovation Research (SBIR) grant aimed at enhancing their LinkPrep™ technology for oncology applications. This funding is not only a recognition of their pioneering work but also a significant step toward transforming cancer research. The grant will be instrumental in advancing rapid, high-resolution genomics technologies that will support cancer detection and profiling.
Importance of Innovation in Cancer Research
In oncology, the ability to analyze genetic information quickly and accurately is crucial. Dovetail's LinkPrep™ technology offers a cutting-edge approach, leveraging existing short-read sequencing technologies to identify structural variants (SVs) in various cancer types. This new grant will facilitate further development of an automated high-throughput platform designed to improve the efficiency and sensitivity of genomic profiling in clinical settings.
Grant Details and Purpose
The grant awarded by the National Human Genome Research Institute will support the commercialization of a robust Hi-C platform, which is being developed for profiling multiple cancer sample types. By incorporating automation and high-throughput analysis capabilities, Dovetail aims to make significant advancements in the detection of complex genomic alterations linked to various cancers.
CEO’s Insight on the New Funding
CEO Matt Easterday expressed excitement over the grant, stating, "We are thrilled about this award. Structural variations are significant in many cancers, and current technologies are often unable to identify these effectively. The grant is an opportunity to optimize our LinkPrep™ technology further, allowing us to offer enhanced detection capabilities across various sample types, which is essential for oncology research." This commitment positions Dovetail at the forefront of groundbreaking developments in cancer genomics.
Showcasing LinkPrep™ Technology at Conferences
Dovetail Genomics plans to exhibit its advancements in LinkPrep™ technology at major genomic conferences. The upcoming participation at the American Society of Human Genetics (ASHG) conference presents an ideal venue for showcasing these innovations. Attendees will have the unique opportunity to learn more about the high-throughput capabilities and practical applications of LinkPrep™ for somatic variant discovery, making it a highly anticipated event in the genomics community.
Engagement at ASHG Conference
At the ASHG 2024 conference, Dovetail will present a session titled "Improved Somatic Variation Detection with Short Reads Using LinkPrep Technology." This session will feature prominent researchers discussing the effectiveness of LinkPrep in detecting elusive variants and the potential implications for cancer diagnostics. Such events play a vital role in sharing knowledge and forging collaborations within the field.
About Dovetail Genomics
Dovetail Genomics is a leader in providing genomic solutions focused on unraveling the complexities of genomic architecture. They utilize their proprietary proximity ligation technologies to provide unique insights into 3D genome organization and variations, which are crucial in numerous areas of biological research, including cancer, epigenetics, and microbiome studies. With a commitment to innovation and quality, Dovetail continues to empower researchers worldwide to solve challenging scientific questions.
Frequently Asked Questions
What is the significance of the recent SBIR grant awarded to Dovetail Genomics?
The SBIR grant will fund the development of Dovetail's LinkPrep™ technology for improved genomic profiling in cancer research, enhancing detection and sensitivity.
What is LinkPrep™ technology?
LinkPrep™ is a genomic profiling tool designed to detect structural variants in cancer samples using an advanced linked-read approach, significantly boosting the accuracy of detection.
Where can I learn more about Dovetail Genomics?
More information about Dovetail Genomics and their innovative solutions can be found on their official website.
How does Dovetail Genomics impact cancer research?
Dovetail's technology allows for a more precise genomic analysis, which is crucial in understanding and treating different forms of cancer more effectively.
What events is Dovetail Genomics participating in to showcase their research?
Dovetail will be showcasing their technology at the ASHG 2024 conference, providing insights into their advancements in somatic variant detection.
